We are live on ! Find out more
Calamos Advisors

Calamos Advisors Portfolio holdings

AUM $28.2B
1-Year Est. Return 21.78%
This Fund
S&P 500
This Quarter Est. Return
+0.71%
1 Year Est. Return
+21.78%
3 Year Est. Return
+69.57%
5 Year Est. Return
+92%
10 Year Est. Return
+282.63%
AUM
$22.9B
AUM Growth
+$1.01B
Cap. Flow
-$5.41B
Cap. Flow %
-23.63%
Top 10 Hldgs %
20.65%
Holding
1,090
New
128
Increased
343
Reduced
93
Closed
104

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$41.8M
2
AAPL icon
Apple
AAPL
+$35.4M
3
AMZN icon
Amazon
AMZN
+$34.6M
4
AESC
The AES Corporation
AESC
+$30.3M
5
ADBE icon
Adobe
ADBE
+$25.6M

Sector Composition

Rank Sector Weight
1 Technology 15.1%
2 Financials 8.11%
3 Healthcare 7.32%
4 Consumer Discretionary 6.91%
5 Communication Services 6.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASML icon
126
ASML
ASML
$636B
$27.1M 0.12%
36,399
-3,403
-9% -$2.67M
TXN icon
127
Texas Instruments
TXN
$255B
$26.4M 0.12%
137,170
+12,541
+10% +$2.39M
CCI icon
128
Crown Castle
CCI
$32.4B
$26.3M 0.11%
151,818
+6,618
+5% +$1.28M
SNOW icon
129
Snowflake
SNOW
$94.6B
$26.3M 0.11%
86,975
-396
-0.5% -$113K
PPG icon
130
PPG Industries
PPG
$26.4B
$26.1M 0.11%
182,648
-50,507
-22% -$8.1M
HES
131
DELISTED
Hess
HES
$26.1M 0.11%
334,354
+17,709
+6% +$1.3M
UPS icon
132
United Parcel Service
UPS
$96B
$25.7M 0.11%
141,245
+12,776
+10% +$2.52M
SPGI icon
133
S&P Global
SPGI
$130B
$25.7M 0.11%
60,428
+5,330
+10% +$2.31M
DFS
134
DELISTED
Discover Financial Services
DFS
$25.5M 0.11%
207,803
+7,197
+4% +$902K
BA icon
135
Boeing
BA
$167B
$25.4M 0.11%
115,666
-45,123
-28% -$10.1M
APTV icon
136
Aptiv
APTV
$12.2B
$25.4M 0.11%
170,763
+6,770
+4% +$1.05M
CB icon
137
Chubb
CB
$139B
$25.1M 0.11%
144,879
+8,552
+6% +$1.5M
DXCM icon
138
DexCom
DXCM
$28.3B
$24.6M 0.11%
179,864
-14,096
-7% -$1.78M
CVS icon
139
CVS Health
CVS
$137B
$24.3M 0.11%
286,433
+24,032
+9% +$2.01M
DAL icon
140
Delta Air Lines
DAL
$57B
$24.1M 0.11%
565,789
+23,406
+4% +$956K
MRVL icon
141
Marvell Technology
MRVL
$170B
$23.7M 0.1%
392,919
-33,947
-8% -$2.04M
RCL icon
142
Royal Caribbean
RCL
$81.8B
$23.7M 0.1%
266,083
+10,918
+4% +$883K
ADP icon
143
Automatic Data Processing
ADP
$102B
$23.3M 0.1%
116,724
+10,300
+10% +$2.12M
CELH icon
144
Celsius Holdings
CELH
$7.36B
$23.3M 0.1%
775,497
+21,387
+3% +$550K
PXD
145
DELISTED
Pioneer Natural Resource Co.
PXD
$22.8M 0.1%
137,160
+9,523
+7% +$1.44M
DHI icon
146
D.R. Horton
DHI
$41.3B
$22.7M 0.1%
269,833
-62,871
-19% -$5.79M
GILD icon
147
Gilead Sciences
GILD
$162B
$22.6M 0.1%
323,934
+25,507
+9% +$1.79M
HBAN icon
148
Huntington Bancshares
HBAN
$34.7B
$22.5M 0.1%
1,452,558
+931,058
+179% +$13.7M
MO icon
149
Altria Group
MO
$122B
$22.4M 0.1%
492,657
+38,287
+8% +$1.85M
NEE.PRP
150
DELISTED
NextEra Energy, Inc. 5.279% Corporate Units
NEE.PRP
$22.4M 0.1%
438,605

Similar funds

Calamos Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, Calamos Advisors held 1,090 positions worth $22.9B, up 4.6% from $21.9B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Calamos Advisors withdrew a net $5.41B in Q3 2021, closing 104 positions and reducing 93 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $31.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Calamos Advisors opened a new position in AstraZeneca worth $17.8M.

  • Calamos Advisors's largest Q3 2021 buy was AstraZeneca: 148,454 shares worth $17.8M.
  • Calamos Advisors added most to Microsoft in Q3 2021, an estimated $41.8M increase.
  • Calamos Advisors's biggest Q3 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $236M.
  • Calamos Advisors fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $31.2M.
  • Calamos Advisors's ten largest holdings make up 21% of its $22.9B portfolio in Q3 2021.
  • Calamos Advisors opened 128 new positions and closed 104 in Q3 2021.
  • Calamos Advisors's portfolio value rose 4.6% quarter-over-quarter to $22.9B.

Based on Calamos Advisors's 13F filing for Q3 2021, filed 26 Oct 2021.